DK1427732T3 - Spirocyclisk-6,7-dihydro-5H-pyrazolo[1,2-a] pyrazol-1-oner som kontrollerer inflammatoriske cytokiner - Google Patents

Spirocyclisk-6,7-dihydro-5H-pyrazolo[1,2-a] pyrazol-1-oner som kontrollerer inflammatoriske cytokiner

Info

Publication number
DK1427732T3
DK1427732T3 DK02799017T DK02799017T DK1427732T3 DK 1427732 T3 DK1427732 T3 DK 1427732T3 DK 02799017 T DK02799017 T DK 02799017T DK 02799017 T DK02799017 T DK 02799017T DK 1427732 T3 DK1427732 T3 DK 1427732T3
Authority
DK
Denmark
Prior art keywords
spirocyclic
pyrazolo
pyrazol
dihydro
inflammatory cytokines
Prior art date
Application number
DK02799017T
Other languages
English (en)
Inventor
Adam Golebiowski
Todd Andrew Brugel
Matthew John Laufersweiler
Michael Phillip Clark
Jane Far-Jine Djung
Biswanath De
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of DK1427732T3 publication Critical patent/DK1427732T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK02799017T 2001-09-20 2002-09-20 Spirocyclisk-6,7-dihydro-5H-pyrazolo[1,2-a] pyrazol-1-oner som kontrollerer inflammatoriske cytokiner DK1427732T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32362501P 2001-09-20 2001-09-20

Publications (1)

Publication Number Publication Date
DK1427732T3 true DK1427732T3 (da) 2006-10-30

Family

ID=23259997

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02763693T DK1427728T3 (da) 2001-09-20 2002-09-20 6,7 -dihydro-5H-pyrazolo[1,2a]pyrazol-1-oner, som kontrollerer inflammatoriske cytokiner
DK02799017T DK1427732T3 (da) 2001-09-20 2002-09-20 Spirocyclisk-6,7-dihydro-5H-pyrazolo[1,2-a] pyrazol-1-oner som kontrollerer inflammatoriske cytokiner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK02763693T DK1427728T3 (da) 2001-09-20 2002-09-20 6,7 -dihydro-5H-pyrazolo[1,2a]pyrazol-1-oner, som kontrollerer inflammatoriske cytokiner

Country Status (32)

Country Link
US (2) US6821971B2 (da)
EP (3) EP1427732B1 (da)
JP (3) JP2005504081A (da)
KR (4) KR20040035837A (da)
CN (3) CN1249066C (da)
AR (3) AR037502A1 (da)
AT (3) ATE287887T1 (da)
AU (2) AU2002334641B2 (da)
BR (3) BR0212673A (da)
CA (3) CA2461073A1 (da)
CO (3) CO5560590A2 (da)
CY (1) CY1106398T1 (da)
CZ (3) CZ2004361A3 (da)
DE (3) DE60213108T2 (da)
DK (2) DK1427728T3 (da)
EG (2) EG24413A (da)
ES (3) ES2237691T3 (da)
HU (3) HUP0500752A2 (da)
IL (3) IL160741A0 (da)
MA (3) MA27065A1 (da)
MX (3) MXPA04002574A (da)
MY (2) MY129329A (da)
NO (2) NO20041594L (da)
NZ (3) NZ531123A (da)
PE (3) PE20030430A1 (da)
PL (3) PL370415A1 (da)
PT (3) PT1427728E (da)
RU (3) RU2299885C2 (da)
SA (1) SA03230529B1 (da)
SK (3) SK1492004A3 (da)
WO (3) WO2003024973A1 (da)
ZA (3) ZA200401260B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087615B2 (en) 2001-09-20 2006-08-08 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US6849627B2 (en) 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US6677337B2 (en) * 2002-03-19 2004-01-13 The Procter & Gamble Company 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
US6967254B2 (en) * 2002-09-09 2005-11-22 Amgen Inc. Substituted heterocyclic compounds and methods of use
CA2520894C (en) * 2003-04-03 2013-02-05 Werner Mederski Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
KR20080111144A (ko) * 2006-04-18 2008-12-22 아보트 러보러터리즈 바닐로이드 수용체 서브타입 1(vr1)의 길항제 및 이의 용도
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
EP2432767B1 (en) * 2009-05-19 2013-06-26 Dow AgroSciences LLC Compounds and methods for controlling fungi
CN107636366B (zh) 2015-06-15 2021-03-12 卡明斯公司 燃烧室弹性装置
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
CN107033090B (zh) * 2017-05-16 2019-05-07 无锡捷化医药科技有限公司 一种1,2,3,4-四氢噌啉的制备方法
RU2721684C1 (ru) * 2019-09-06 2020-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Метил 2,3,8-триоксо-4-фенилтетрагидро-6Н-пиразоло[1,2-а]пирроло[2,3-c]пиразол-9а(1Н)-карбоксилаты
EP4422621A4 (en) * 2021-10-27 2025-08-27 Merck Sharp & Dohme Llc SPIROTRICYCLIC RIPK1 INHIBITORS AND METHODS OF USE THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054291A (da) * 1963-02-26
GB1124982A (en) * 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529154A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
ATE182892T1 (de) * 1992-05-15 1999-08-15 Merrell Pharma Inc Mercaptoacetylamide von pyridazo(1,2-a>(1,2>- diazepin -derivaten als eukephalinase und ace- inhibitoren
GB9303993D0 (en) * 1993-02-26 1993-04-14 Fujisawa Pharmaceutical Co New heterocyclic derivatives
HU229958B1 (hu) * 1999-09-07 2015-03-30 Syngenta Participations Ag Herbicid vegyületek, ezeket tartalmazó készítmények, eljárás a vegyületek előállítására, valamint eljárás gyomnövények irtására
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
PL370351A1 (en) 2005-05-16
HUP0402500A2 (hu) 2005-03-29
NZ531123A (en) 2006-08-31
NO20041605L (no) 2004-06-21
PL370415A1 (en) 2005-05-30
PE20030430A1 (es) 2003-06-24
ATE356126T1 (de) 2007-03-15
ZA200401403B (en) 2004-08-30
DK1427728T3 (da) 2007-07-09
CO5560590A2 (es) 2005-09-30
MXPA04002574A (es) 2004-06-18
RU2278864C2 (ru) 2006-06-27
DE60218704T2 (de) 2007-11-08
CZ2004358A3 (cs) 2004-07-14
CO5560579A2 (es) 2005-09-30
NZ531063A (en) 2007-08-31
KR20060036125A (ko) 2006-04-27
ZA200401260B (en) 2004-08-30
PE20030474A1 (es) 2003-07-22
KR100656126B1 (ko) 2006-12-12
ES2268154T3 (es) 2007-03-16
CN1555379A (zh) 2004-12-15
NZ531122A (en) 2005-09-30
EP1427727B1 (en) 2005-01-26
DE60213108T2 (de) 2007-02-08
SK1482004A3 (en) 2004-08-03
JP2005504083A (ja) 2005-02-10
BR0212905A (pt) 2004-10-13
AR037502A1 (es) 2004-11-17
AU2002327690B2 (en) 2006-07-20
MXPA04002570A (es) 2004-05-31
PT1427732E (pt) 2006-12-29
ATE332901T1 (de) 2006-08-15
HUP0402500A3 (en) 2008-10-28
NO20041594L (no) 2004-06-21
WO2003024973A1 (en) 2003-03-27
PT1427728E (pt) 2007-05-31
CN1250551C (zh) 2006-04-12
DE60213108D1 (de) 2006-08-24
CZ2004345A3 (cs) 2004-06-16
EP1427732B1 (en) 2006-07-12
HUP0402378A2 (hu) 2005-02-28
ES2237691T3 (es) 2005-08-01
IL160741A0 (en) 2004-08-31
US20030105084A1 (en) 2003-06-05
PT1427727E (pt) 2005-06-30
CN1555375A (zh) 2004-12-15
CN1249066C (zh) 2006-04-05
BR0212673A (pt) 2004-08-24
AR037237A1 (es) 2004-11-03
CA2461072A1 (en) 2003-03-27
AR037145A1 (es) 2004-10-27
EG24413A (en) 2009-05-25
DE60202782T2 (de) 2006-01-19
JP2005504081A (ja) 2005-02-10
US6821971B2 (en) 2004-11-23
RU2004111806A (ru) 2005-03-27
EP1427728B1 (en) 2007-03-07
KR20040035835A (ko) 2004-04-29
CA2461073A1 (en) 2003-03-27
SA03230529B1 (ar) 2008-06-21
BR0212716A (pt) 2004-08-03
AU2002334641B2 (en) 2007-03-29
CA2461071A1 (en) 2003-03-27
HUP0500752A2 (en) 2006-01-30
CY1106398T1 (el) 2011-10-12
ZA200401402B (en) 2004-08-27
SK1492004A3 (en) 2004-11-03
HK1071565A1 (en) 2005-07-22
SK1502004A3 (en) 2004-09-08
EP1427728A1 (en) 2004-06-16
CZ2004361A3 (cs) 2004-07-14
KR20040035837A (ko) 2004-04-29
MA27064A1 (fr) 2004-12-20
PL370362A1 (en) 2005-05-16
CN1556811A (zh) 2004-12-22
RU2004111805A (ru) 2005-04-10
RU2272040C2 (ru) 2006-03-20
MXPA04002569A (es) 2004-05-31
US6566357B1 (en) 2003-05-20
KR100623879B1 (ko) 2006-09-19
IL160682A0 (en) 2004-08-31
KR20040035836A (ko) 2004-04-29
MY129329A (en) 2007-03-30
WO2003024970A1 (en) 2003-03-27
JP2005504082A (ja) 2005-02-10
EG24363A (en) 2009-03-04
ATE287887T1 (de) 2005-02-15
ES2282459T3 (es) 2007-10-16
HK1071366A1 (en) 2005-07-15
DE60202782D1 (de) 2005-03-03
CO5560589A2 (es) 2005-09-30
CN1257905C (zh) 2006-05-31
PE20030446A1 (es) 2003-07-21
WO2003024971A1 (en) 2003-03-27
EP1427732A1 (en) 2004-06-16
EP1427727A1 (en) 2004-06-16
IL160742A0 (en) 2004-08-31
HUP0402378A3 (en) 2008-10-28
RU2299885C2 (ru) 2007-05-27
DE60218704D1 (de) 2007-04-19
MA27065A1 (fr) 2004-12-20
RU2004111803A (ru) 2005-10-10
MY129069A (en) 2007-03-30
MA27066A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
DK1381363T3 (da) Imidazo[1,2-a]pyridinderivater som mGluR5-antagonister
NO20035476D0 (no) Azaindoler
NO20042755L (no) Amidsubstituerte imidazopyridiner
MXPA03008144A (es) Nuevos compuestos antiinflamatorios de triazolopiridinas.
DK1608654T3 (da) 8-substituerede-6, 7, 8, 9-tetrahydropyrimido (1,2- a) pyrimidin-4-on-derivater
DE50202178D1 (de) Neue sulfonat-substituierte pyrazolopyridinderivate
DK1427728T3 (da) 6,7 -dihydro-5H-pyrazolo[1,2a]pyrazol-1-oner, som kontrollerer inflammatoriske cytokiner
DK1608653T3 (da) Substituerede 8-perfluoroalkyl-6,7,8,9- tetrahydropyrimido (1,2-a) pyrimidin-4-on derivater
AU2002353719A1 (en) Heat controlled optoelectrical unit
DE60205921D1 (de) SUBSTITUIERTE 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDOç1,2-A!PYRIMIDIN-4-ON- UND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO-ç1,2-A!PYRIMIDIN-5(1H)ONDERIVATE
AU2003255323A1 (en) Imidazo`1,2-a!pyridines
MXPA03007623A (es) Derivado de piridopirimidina o naftiridina.
AU2002328883A1 (en) Thiazolo (4,5-b)pyridines as fungicides
PT1326866E (pt) 3,4-di-hidropirido[1,2-a]pirimidinas substituidas
AUPR795101A0 (en) Central shutter controller
HK1080454A (en) 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
AU2002318478A1 (en) Zeolite ssz-59
AU2002233664A1 (en) Naphthyridine derivative
AU2002327093A1 (en) 1,2-dihydro-2-oxo-1,8-naphthyridine derivative
AU2002310558A1 (en) Rubberized house structure
HK1064373A (en) Novel imidazopyridine compounds with therapeutic effect
ITMI20011661A0 (it) Gruppo verniciatura
HK1063470A (en) Azaindoles
HK1073655A (en) Nitrosated imidazopyridines
DK1326866T3 (da) Substituerede 3,4-dihydro-pyrido[1,2-a]pyrimidiner